MiR-148a and miR-27b were reported to destabilize USP4 mRNA by targeting its 3′-UTR in HCC, breast cancer, and liver fibrosis (Heo et al., 2014; Zhang et al., 2017; Wu et al., 2019). Here, USP4 is linked to hepatocellular carcinoma.